245 related articles for article (PubMed ID: 15153888)
1. The effect of two skin cleansing systems on moderate xerotic eczema.
Draelos ZD; Ertel K; Hartwig P; Rains G
J Am Acad Dermatol; 2004 Jun; 50(6):883-8. PubMed ID: 15153888
[TBL] [Abstract][Full Text] [Related]
2. The effect of ceramide-containing skin care products on eczema resolution duration.
Draelos ZD
Cutis; 2008 Jan; 81(1):87-91. PubMed ID: 18306855
[TBL] [Abstract][Full Text] [Related]
3. Soak and smear: a standard technique revisited.
Gutman AB; Kligman AM; Sciacca J; James WD
Arch Dermatol; 2005 Dec; 141(12):1556-9. PubMed ID: 16365257
[TBL] [Abstract][Full Text] [Related]
4. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba.
Fujita WH; McCormick CL; Parneix-Spake A
Int J Dermatol; 2007 Jul; 46(7):700-5. PubMed ID: 17614797
[TBL] [Abstract][Full Text] [Related]
5. Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial.
Faurschou A; Wulf HC
Arch Dermatol; 2008 May; 144(5):620-4. PubMed ID: 18490588
[TBL] [Abstract][Full Text] [Related]
6. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
7. In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.
Gans EH; Sadiq I; Stoudemayer T; Stoudemayer M; Kligman AM
J Drugs Dermatol; 2008 Jan; 7(1):28-32. PubMed ID: 18246695
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).
Eberlein B; Eicke C; Reinhardt HW; Ring J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):73-82. PubMed ID: 18181976
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunohistochemical study of the effect of a cosmetic product in patients with asteatotic eczema.
Caproni M; Torchia D; Pestelli E; Volpi W; Fabbri P; Schincaglia E
Int J Tissue React; 2005; 27(1):23-9. PubMed ID: 15847102
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
Faghihi G; Iraji F; Shahingohar A; Saidat A
J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
[TBL] [Abstract][Full Text] [Related]
11. Moisturizing effects of topical nicotinamide on atopic dry skin.
Soma Y; Kashima M; Imaizumi A; Takahama H; Kawakami T; Mizoguchi M
Int J Dermatol; 2005 Mar; 44(3):197-202. PubMed ID: 15807725
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus.
Gorouhi F; Solhpour A; Beitollahi JM; Afshar S; Davari P; Hashemi P; Nassiri Kashani M; Firooz A
J Am Acad Dermatol; 2007 Nov; 57(5):806-13. PubMed ID: 17658663
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
[TBL] [Abstract][Full Text] [Related]
14. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study.
Szczepanowska J; Reich A; Szepietowski JC
Pediatr Allergy Immunol; 2008 Nov; 19(7):614-8. PubMed ID: 18208463
[TBL] [Abstract][Full Text] [Related]
15. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.
Luger TA; Lahfa M; Fölster-Holst R; Gulliver WP; Allen R; Molloy S; Barbier N; Paul C; Bos JD
J Dermatolog Treat; 2004 Jun; 15(3):169-78. PubMed ID: 15204150
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
17. Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: A randomized comparative study.
Malhotra AK; Khaitan BK; Sethuraman G; Sharma VK
J Am Acad Dermatol; 2008 Apr; 58(4):596-602. PubMed ID: 18158199
[TBL] [Abstract][Full Text] [Related]
18. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.
Smith JG; Wehr RF; Chalker DK
Arch Dermatol; 1976 Aug; 112(8):1115-7. PubMed ID: 952530
[TBL] [Abstract][Full Text] [Related]
20. Patient satisfaction with budesonide Turbuhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler in a managed care setting.
Weiss KB; Paramore LC; Liljas B; Revicki DA; Luce BR
J Asthma; 2005 Nov; 42(9):769-76. PubMed ID: 16316872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
